Page last updated: 2024-08-24

3-iodobenzylguanidine and ganglioside, gd2

3-iodobenzylguanidine has been researched along with ganglioside, gd2 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, K; Dopfer, R; Gillies, SD; Handgretinger, R; Klingebiel, T; Lang, P; Neithammer, D; Reisfeld, RA; Reuland, P; Schrappe, M	1
Bares, R; Geiger, L; Haase, B; Handgretinger, R; Müller-Schauenburg, W; Niethammer, D; Reuland, P; Thelen, MH	1
George, RE; Matthay, KK; Yu, AL	1

Reviews

1 review(s) available for 3-iodobenzylguanidine and ganglioside, gd2

Article	Year
Promising therapeutic targets in neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, May-15, Volume: 18, Issue:10 Topics: 3-Iodobenzylguanidine; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal; Child; Child, Preschool; Combined Modality Therapy; Crizotinib; Gangliosides; Humans; Molecular Targeted Therapy; Neural Crest; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Precision Medicine; Pyrazoles; Pyridines; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases	2012

Article

Year

Promising therapeutic targets in neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, May-15, Volume: 18, Issue:10

Topics: 3-Iodobenzylguanidine; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal; Child; Child, Preschool; Combined Modality Therapy; Crizotinib; Gangliosides; Humans; Molecular Targeted Therapy; Neural Crest; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Precision Medicine; Pyrazoles; Pyridines; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases

2012

Trials

1 trial(s) available for 3-iodobenzylguanidine and ganglioside, gd2

Article	Year
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:2 Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Child; Child, Preschool; Female; Gangliosides; Hemolysis; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Neuroblastoma; Radionuclide Imaging	1995

Article

Year

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma.

European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:2

Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Child; Child, Preschool; Female; Gangliosides; Hemolysis; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Neuroblastoma; Radionuclide Imaging

1995

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and ganglioside, gd2

Article	Year
Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:7 Topics: 3-Iodobenzylguanidine; Adolescent; Antibodies, Monoclonal; Bone Neoplasms; Child; Child, Preschool; False Negative Reactions; Female; Fluorescent Antibody Technique; Follow-Up Studies; Gangliosides; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Fusion Proteins; Soft Tissue Neoplasms; Technetium	2001

Article

Year

Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response.

Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:7

Topics: 3-Iodobenzylguanidine; Adolescent; Antibodies, Monoclonal; Bone Neoplasms; Child; Child, Preschool; False Negative Reactions; Female; Fluorescent Antibody Technique; Follow-Up Studies; Gangliosides; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Fusion Proteins; Soft Tissue Neoplasms; Technetium

2001